HIPRA, a multinational pharmaceutical company that develops vaccines for animal health, is constructing their North American headquarters at the South Jersey Technology Park at Rowan University.
The structure, which will be built on 375,000 square feet on the campus, will be dedicated to R&D, manufacturing, distribution, and office space. The development is expected to create 200 jobs.
“We selected the Technology Park after evaluating numerous first-class host sites,” said Arnau Nogareda, Managing Director of HIPRA in a Rowan Today article. “We were impressed by the research already being done at Rowan and the Technology Park, in particular in the areas of science and engineering; access to outstanding faculty and student teams; support from New Jersey, Gloucester County and Mantua Township; and a location in the heart of the East Coast.”
Close proximity to the Philadelphia Airport and a flourishing life sciences environment were large draws for the company as well.
HIPRA will join the over eighty percent of U.S. pharmaceutical and biotech companies that have a presence in the Delaware, New Jersey, and Pennsylvania corridor.